This live facilitated two-part course provides clinicians the knowledge and confidence to prescribe gender affirming hormone therapy (GAHT) based on the needs of their patient population utilising an informed consent model. Additionally, supporting clinicians to create a gender affirming practice and establishing a business model for ongoing financial sustainability.